Soft bone-hard arteries: A link?

Kidney and Blood Pressure Research

Volumn 34, Issue 4, 2011, Pages 203-208

  London, Gérard M ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Bone disorders; Chronic kidney disease; Extraosseous and cardiovascular calcifications

Indexed keywords

AGING; ARTERY CALCIFICATION; BLOOD VESSEL CALCIFICATION; BONE METABOLISM; BONE MINERAL; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; KIDNEY FAILURE; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL;

BONE AND BONES; BONE DISEASES; CALCINOSIS; HUMANS; KIDNEY FAILURE, CHRONIC; VASCULAR CALCIFICATION;

EID: 79959497103     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000327004     Document Type: Conference Paper

References (53)

1. Braun J, Oldendorf M, Moshage W, et al: Electron-beam computed tomography in the evaluation of cardiac calcifications in chron-ic dialysis patients. Am J Kidney Dis 1996; 27: 394-401. (Pubitemid 26075849)
2. London GM, Guérin AP, Marchais SJ, et al: Arterial media calcification in end-stage re-nal disease: impact on all-cause and cardio-vascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
3. Guérin AP, London GM, Marchais SJ, Mé-tivier F: Arterial stiffening and vascular cal-cifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15:1014-1021.
4. Schoppet M, Shroff RC, Hofbauer LC, Sha-nahan CM: Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 2008; 73: 384-390. (Pubitemid 351186286)
5. Demer LL, Tintut Y: Vascular calcification: pathobiology of multifaceted disease. Circulation 2008; 117: 2938-2948. (Pubitemid 351787058)
6. Reynolds JL, Joannides AJ, Skepper JN, et al: Human vascular smooth muscle cells under-go vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mech-anism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15:2857-2867. (Pubitemid 41103395)
7. Schulz E, Arfai K, Liu X, et al: Aortic calcifi-cation and the risk of osteoporosis and frac-tures. J Clin Endocrin Metab 2004; 89:4246-4253. (Pubitemid 39244420)
8. Hamerman D: Osteoporosis and atheroscle-rosis: biological linkage and the emergence of dual-purpose therapies. Q J Med 2005; 98: 467-484. (Pubitemid 41430104)
9. Tanko LB, Christiansen C, Cox DA, et al: Re-lationship between osteoporosis and cardio-vascular disease in postmenopausal women. J Bone Mineral Res 2005; 20: 1912-1920. (Pubitemid 41532776)
10. Sumino H, Ichikawa S, Kasama S, et al: Elevated arterial stiffness in postmenopausal women with osteoporosis. Maturitas 2006; 55:212-218. (Pubitemid 44404157)
11. Barreto DV, Barreto FC, Carvalho AB, Cup-pari L, Cendoroglo M, Draibe SA, Moyses RM, Neves KR Jorgetti V, Blair A, Guiber-teau R, Fernandes Canziani ME: Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-relat-ed risk factors. Kidney Int 2005; 67:1576-1582. (Pubitemid 40463138)
12. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951. (Pubitemid 38822076)
13. Adragao T, Herberth J, Monier-Faugere M-C, et al: Low bone volume-a risk factor for coronary calcifications in hemodialysis patients. Clin J Am Soc Nephrol 2009; 4:450-455.
14. London GM, Marchais SJ, Guérin AP, et al: Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008; 19: 1827-1835.
15. Joki N, Hase H, Shiratake M, et al: Calcaneal osteopenia is a new marker for arterial stiff-ness in chronic hemodialysis patients. Am J Nephrol 2005; 25: 196-202. (Pubitemid 41202740)
16. Raggi P, Bellasi A, Ferramosca E, et al: Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hy-pertension 2007; 49:1278-1284. (Pubitemid 46809369)
17. Toussaint ND, Lau KK, Strauss BJ, et al: Association between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 586-593. (Pubitemid 351767633)
18. Bridgeman G, Brookes M: Blood supply to the human femoral diaphysis in youth and senescense. J Anat 1996; 188: 611-621. (Pubitemid 26232203)
19. Ramseier E: Untersuchungen über arteri-osklerotische Veränderungen der Knochen-arterien. Wirchow Arch Path Anat 1962; 336: 77-86.
20. Alagiakrishnan K, Juby A, Hanley D, et al: Role of vascular factors in osteoporosis. J Gerontol 2008; 4: 362-366. (Pubitemid 36397053)
21. Griffith JF, Yeung DK, Tsang PH, et al: Com-promised bone marrow perfusion in osteo-porosis. J Bone Miner Res 2008; 23: 1068-1075. (Pubitemid 351915729)
22. Laroche M: Intraosseous circulation from physiology to disease. Joint Bone Spine 2002; 69: 262-269. (Pubitemid 34654360)
23. Parhami F, Garfinkel A, Demer LL: Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 2000; 20: 2346-2348.
24. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS: Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre-and post-menopausal women: evidence for a link be-tween systemic inflammation and osteopo-rosis. Osteoporos Int 2005; 16:1263-1271. (Pubitemid 41396955)
25. Gerdhem P, Obrant KJ: Effects of cigarette smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultra-sound. Osteoporos Int 2002; 13: 932-936. (Pubitemid 36050270)
26. Mody N, Parhami F, Sarafian TA, Demer LL: Oxidative stress modulates osteoblastic dif-ferentiation of vascular and bone cells. Free Radic Biol Med 2001; 31: 509-519. (Pubitemid 32728438)
27. Tanikawa T, Okada Y, Tanikawa R, Tanaka Y: Advanced glycation end-products induce calcification of vascular smooth muscle cell throughout RAGE/p38MAPK. J Vasc Res 2009; 46: 572-580.
28. Hjortnaes J, Butcher J, Figueiredo J-L, et al: Arterial and aortic valve calcification in-versely correlates with osteoporotic bone re-modelling: a role of inflammation. Eur Heart J 2010; 31: 1975-1984.
29. Aikawa E, Nahrendorf N, Figueiredo J-L, et al: Osteogenesis associates with inflamma-tion in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007; 116:2841-2850. (Pubitemid 350301146)
30. Deguchi J-O, Aikawa M, Tung C-H, et al: In-flammation in atherosclerosis: visualizing matrix metalloproteinase action in macro-phages in vivo. Circulation 2006; 114:55-62. (Pubitemid 44305275)
31. Aikawa E, Nahrendorf M, Sosnovik D, et al: Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007; 115: 377-386. (Pubitemid 46148512)
32. Aikawa E, Aikawa M, Libby P, et al: Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009; 119:1785-1794.
33. -/- mice. Arterioscler Thromb Vasc Biol 2007; 27:2589-2596. (Pubitemid 350158910)
34. Shao J-S, Al-Aly Z, Lai Ch-T, et al: Vascular Bmp-Msx2-Wnt signaling and oxidative stress in arterial calcification. Ann NY Acad Sci 2007; 1117:40-50. (Pubitemid 350191291)
35. Hofbauer LC, Schoppet M: Clinical implica-tions of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 2004; 292:490-495. (Pubitemid 38988958)
36. Collin-Osdoby P: Regulation of vascular cal-cification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004; 95:1046-1057. (Pubitemid 39557891)
37. Teitelbaum SL: Osteoclasts; culprit in in-flammatory osteolysis. Arthritis Res Ther 2006; 8:1-8.
38. Flore CE, Pennisi P, Ferro G, et al: Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. Horm Metab Res 2006; 38:417-422. (Pubitemid 44055792)
39. Bucay N, Sarosi I, Dunstan CR, et al: Osteo-protegerin-deficient mice develop early on-set osteoporosis and arterial calcification. Genes Dev 1998; 12:1260-1268. (Pubitemid 28213402)
40. Panizo S, Cardus A, Encinas M, et al: RANKL increases vascular smooth muscle cell calci-fication through a RANK-BMP4-dependent pathway. Circ Res 2009; 104:1041-1048.
41. Moe S, Drüeke T, Cunningham J, et al: Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Out-comes (KDIGO). Kidney Int 2006; 69: 1945-1953. (Pubitemid 43924257)
42. Huang JC, Sakata T, Pfleger LL, et al: PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 2004; 19: 234-244.
43. Shao J-S, Cheng S-L, Charlton-Kachigian N, et al: Teriparatide (human parathyroid hor-mone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipopro-tein recepto-deficient mice. J Biochem Chemistry 2003; 278: 50195-50202. (Pubitemid 37548859)
44. Cheng S-L, Shao J-S, Halstead LR, et al: Ac-tivation of vascular smooth muscle parathy-roid receptor inhibits Wnt/ß-catenin signal-ing and aortic fibrosis in diabetic arterioscle-rosis. Circ Res 2010; 107:271-282.
45. Lee NK, Sowa H, Hinoi E, et al: Endocrine regulation of energy metabolism by the skel-eton. Cell 2007; 130: 456-469. (Pubitemid 47208519)
46. Ferron M, Hinoi E, Karsenty G, Ducy P: Osteocalcin differentially regulates B cells and adipocytes gene expression and affects the development of metabolic disease in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270. (Pubitemid 351738545)
47. Kanazawa I, Yamaguchi T, Yamamoto M, et al: Serum osteocalcin is associated with glu-cose metabolism and atherosclerosis param-eters in type 2 diabetes mellitus. J Clin Endo-crinol Metab 2009; 94: 45-49.
48. Bacchetta J, Boutroy S, Guebre-Egzlabher F, et al: The relationship between adipokines, osteocalcin and bone quality in chronic kid-ney disease. Nephrol Dial Transplant 2009; 24:3120-3125.
49. Oshima K, Nampei A, Matsuda M, et al: Adiponectin increases bone mass by suppress-ing osteoclasts and activating osteoblasts. Biochem Biophys Res Commun 2005; 331: 520-526. (Pubitemid 40602668)
50. Luo XH, Guo LJ, Yuan LQ, et al: Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005; 309:99-109.
51. Elefteriou F, Takeda S, Ebihara K, et al: Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 2004; 101:3258-3263. (Pubitemid 38327768)
52. Parhami F, Tintut Y, Ballard A, et al: Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 2001; 88: 954-960. (Pubitemid 32441475)
53. Coen G, Ballanti P, Fischer MS, et al: Serum leptin in dialysis renal osteodystrophy. Am J Kidney Dis 2003; 42:1036-1042. (Pubitemid 37322920)